Skip to main content


September 24, 2020
IO Learning invited Dr Nishita Kothary to discuss her 2020 SIR abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness Analysis.”
September 18, 2020
Dr Fabian Laage Gaupp, co-founder of the Tanzanian IR Initiative, discusses the current status of the program, as well as challenges faced during the COVID pandemic.
July 13, 2020
IO Learning invited Bela Kis, MD, PhD, to discuss his 2020 SIR Abstract of the Year, “Transarterial Chemoperfusion Treatment of Unresectable Pleural Mesothelioma: Interim Results of a Phase 2 Prospective Study.”
June 09, 2020
Dr Ripal Gandhi discusses his 2020 SIR abstract, “Overcoming Limitations in the Treatment of Locally Advanced Pancreatic Cancer With Transarterial Microperfusion Utilizing a Novel Dual-Balloon Catheter."
April 18, 2020
Dr Busch spoke with IO Learning about integrating the recently FDA-approved TULSA treatment into his practice.
March 25, 2020
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
March 09, 2020
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
March 06, 2020
Dr Matthew Callstrom shares his thoughts about the importance of learning nerve anatomy to avoid complications during ablation procedures.
February 10, 2020
Dr Strosberg spoke with IO Learning at CIO 2019 about his experience with various embolization techniques and the latest data on these treatment modalities.
February 04, 2020
Dr Padia spoke with IO Learning about his findings on making unresectable patients resectable, success in using a newer technique, and the future of tumor ablation.
January 30, 2020
Dr Zinner is the CEO and Executive Medical Director at Miami Cancer Institute. He spoke with IO Learning about the role of interventional oncology at the Miami Cancer Institute. 
Back to Top